The Federal Circuit's decision on Feb. 23, 2011 in Centocor Ortho Biotech., Inc. v. Abbott Labs., __ F.3d __, 2011 WL 635291 (C.A. Fed. (Tex.) 2011), vacated a $1.67 billion verdict based on invalidity for insufficient written description.
Centocor v. Abbott Labs: Must You Only Preach What You Practice?
The Federal Circuit's decision on Feb. 23, 2011 in <i>Centocor Ortho Biotech., Inc. v. Abbott Labs.</i>, vacated a $1.67 billion verdict based on invalidity for insufficient written description. The case provides an example of when technology can be so complicated or unpredictable that the specification does not adequately explain how to practice the claimed invention.
By
Irah Donner, Matthew Siegal And Clayton McCrawThis premium content is locked for The Intellectual Property Strategist subscribers only
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN The Intellectual Property Strategist
- Stay current on the latest information, rulings, regulations, and trends
- Includes practical, must-have information on copyrights, royalties, AI, and more
- Tap into expert guidance from top entertainment lawyers and experts
Already have an account? Sign In Now
For enterprise-wide or corporate access, please contact Customer Service at [email protected] or call 1-877-256-2473.
